On air · 1 of 3 networks
MEDSIR ads
- medsir.org
- Research Services
- ES
- 163 employees
MEDSIR’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 23. Watch MEDSIR on any plan to get each new one in your feed.
Watchlist included in every plan
What MEDSIR runs
- Single image · LinkedIn
- 6
- Google ad on 3 Nov 2026
- 1
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 7 Nov 2026 | See all 23 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 23 Oct 2026 | Collect them with the API → |
| Running | 1 | Ads on the Google Ads Transparency Center | Checked 3 Nov 2026 | Collect them with the API → |
MEDSIR has no live LinkedIn ads. Its Facebook page had no active ads on 23 Oct 2026, and we recorded 1 Google ad on 3 Nov 2026.
Latest ads
- LINKEDIN · IMAGESince 15 Oct 2026
What could AI change in your oncology practice? From smarter clinical trial design and patient matching to real-world data and personalized treatment decisions, AI is opening new possibilities across oncology. Join leading experts at MEDTALK AI: An open discussion on AI in real-world oncology, taking place alongside ESMO. October 24 | 18:30h at Novotel Madrid Campo de las Naciones, a 5-min walk from the ESMO venue. Request your place.
- LINKEDIN · IMAGESince 15 Oct 2026
Some conversations are too important to miss. Taking place alongside ESMO 2026, MEDSIR's MEDTALK AI will bring oncology experts together to examine what AI means for the future of cancer research and clinical care, from smarter trials and real-world evidence to personalized decision-making and responsible AI. October 24 | 18:30h at Novotel Madrid Campo de las Naciones, a 5-min walk from the ESMO venue. Limited attendance available. Register now to apply.
- LINKEDIN · IMAGESince 15 Oct 2026
MEDSIR at ESMO 2026. From final study results to innovative new research, discover how MEDSIR is advancing oncology through the oral resentation of TUXEDO-3 and the posters of SATROPIN and BEXAR trials. Join us at ESMO 2026 and explore the science shaping tomorrow’s cancer care. Discover our ESMO 2026 research
- LINKEDIN · IMAGESince 15 Oct 2026
From clinical research to AI-driven innovation. Alongside ESMO 2026, MEDSIR brings together scientific expertise and forward-looking thinking, from advancing oncology research to exploring how AI can transform clinical development and decision-making. Join the conversation at MEDSIR's MEDTALK AI: Where AI Meets Clinical Decisions. October 24 | 18:30h at Novotel Madrid Campo de las Naciones, a 5-min walk from the ESMO venue. Request your place.
- LINKEDIN · IMAGESince 18 Aug 2026
Oncologists developing innovative concepts in genitourinary cancers are invited to submit their study proposals and apply for travel support to present and discuss their trial ideas with experts.
- LINKEDIN · IMAGESince 18 Aug 2026
MEDSIR brings selected treatment opportunities and expert mentors together to shape new GU cancer trial concepts.
6 of 23 adsSign up to see every MEDSIR ad, filter by format and date, and get alerts on new ones.
See all 23 adsQuestions about MEDSIR’s ads
Is MEDSIR running LinkedIn ads?
We recorded no live LinkedIn ads for MEDSIR on 8 Nov 2026.
How many LinkedIn ads has MEDSIR run?
LinkedIn’s ad library lists 23 ads for MEDSIR. We recorded 23 LinkedIn ads for MEDSIR, first recorded on 25 Sept 2026 and last recorded on 17 Oct 2026.
Does MEDSIR advertise on Facebook and Instagram?
MEDSIR’s Facebook page had no active ads in Meta’s Ad Library, last recorded on 23 Oct 2026.
Does MEDSIR run Google ads?
Yes. We recorded 1 Google ad for the domain medsir.org on 3 Nov 2026.
Which ad formats does MEDSIR use?
The 6 LinkedIn ads on this page include 6 image ads.
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.